Clinical TrialsSearch results
Number of results: 857
Recruiting
- A Phase 1b/2 Study of Oral HH2853 in Patients with Relapsed/Refractory Peripheral T-cell Lymphoma
- Peripheral T-cell Lymphoma
- Onishi Shintaro
- 2023-04-30
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Other
- A phase 2 study of atezolizumab with carboplatin plus pemetrexed followed by maintenance atezolizumab with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer
- Non-squamous non-small cell lung cancer
- Itani Hidetoshi
- 2020-07-14
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Recruiting
- A PHASE 3 OPEN-LABEL STUDY OF PTC923 (SEPIAPTERIN) IN PHENYLKETONURIA
- Phenylketonuria
- KOBAYASHI Tomoyo
- 2023-08-12
Other
- A Phase 3 Randomized, Open-Label, Multicenter Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation
- Mantle Cell Lymphoma
- Tsuji Hitoshi
- 2021-12-26
Other
- A Phase 3 Study Comparing Pirtobrutinib (LOXO-305) to Bendamustine plus Rituximab in Untreated Patients with CLL/SLL
- Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- Safi Shahda
- 2022-02-18
Other
- A Phase 3 Trial of Neoadjuvant T-DXd Monotherapy or T-DXd followed by THP Compared to ddAC-THP in Participants with High-risk HER2-positive Early-stage Breast Cancer (DESTINY-Breast11)
- HER2-positive early breast cancer
- Inoguchi Akihiro
- 2021-11-02
Recruiting
- A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Setmelanotide in Patients with Acquired Hypothalamic Obesity
- Acquired hypothalamic obesity (HO)
- Flaherty Jim
- 2024-02-22
Not yet recruiting
- A Phase I Dose Fnding Study of Weekly Cisplatin Plus S-1 with Concurrent Proton-beam (or Photon) Therapy for Elderly Patients with Inoperable Stage III Non-Small Cell Lung Cancer.
- Inoperable stage III Non-small Cell Lung Cancer
- Akita Kenji
- 2023-10-21